Protracted Mixture of Local Anesthetics for Major Foot and Ankle Surgery
NCT ID: NCT02526199
Last Updated: 2016-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
56 participants
INTERVENTIONAL
2015-08-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine
NCT01277159
Liposomal Bupivacaine With Dexamethasone for Foot Surgery
NCT06465992
Effect of Ropivacaine During Popliteal Nerve Block in Foot and Ankle Surgery
NCT04872322
Patient-Titrated Automated Intermittent Boluses of Local Anesthetic vs. a Continuous Infusion Via a Perineural Catheter for Postoperative Analgesia
NCT05091905
Dexamethasone & Bupivacaine vs Bupivacaine Alone in Combined Femoral and Sciatic Nerve Block for Perioperative Analgesia in Patients Undergoing Lower Limb Surgeries
NCT02576782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group BA
Bupivacaine + Adrenaline Sciatic nerve block with Bupivacaine 0.5% + Epinephrine 5 microg/ml
Bupivacaine
Sciatic nerve block
Epinephrine
Adjuvant to perinerual block
Group BAD
Bupivacine + Adrenaline + Dexamethasone Sciatic nerve block with Bupivacaine 0.5% + Epinephrine 5 microg/ml PLUS Dexamethsone 8 mg
Bupivacaine
Sciatic nerve block
Epinephrine
Adjuvant to perinerual block
Dexamethasone
Adjuvant to perinerual block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
Sciatic nerve block
Epinephrine
Adjuvant to perinerual block
Dexamethasone
Adjuvant to perinerual block
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled major foot and ankle surgery
* written informed consent
* fertile women in anti conceptive treatment
* fertile women not in anti conceptive treatment, but with negative urin-HCG on day of surgery
Exclusion Criteria
* allergies to medicines involved
* daily buse of steroids
* daily use of opioids
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
Rasmus Wulff Hauritz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rasmus Wulff Hauritz
Consultant Anesthesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesia, Aarhus University Hospital
Aarhus, Region Midt, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-005383-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.